The world's first non-invasive therapeutic drug monitor.
Lumitrace is a wearable device that detects the presence of drugs in the body non-invasively, using only light and optical sensors through the skin.
The problem
Non-adherence to pharmacological treatment is one of modern medicine's greatest challenges. It affects a significant proportion of patients with chronic diseases, drives up healthcare costs, and compromises clinical outcomes. No technology currently exists to verify medication intake non-invasively and automatically.
Our solution
Lumitrace detects the presence of drugs in the body through the skin — no needles, no samples, no disruption. A compact wearable device uses transdermal optical sensors and artificial intelligence to verify drug intake in real time and transmit data to a mobile device.
How it works
Patient takes their medication
The patient takes their medication as usual — no extra steps, no changes to their routine. Nothing different.
Optical detection
The wearable device detects the substance through the skin using only light and optical sensors. No needles. No samples.
AI processing
Data is transmitted to a mobile device and processed by artificial intelligence algorithms.
Real-time results
Intake data is transmitted in real time to a mobile app or clinical platform, enabling immediate monitoring and therapeutic decisions.
Intellectual property
Patent pending before the USPTO — Application #63/824,295.
Current status
Validated in laboratory environment. Ongoing preclinical trials in mice with positive results.